CEMP Key Statistics, Chart & Performance
The current stock price of CEMP is 2.325 null. In the past month the price decreased by -26.77%. In the past year, price decreased by -69.21%.
CEMP Latest News, Press Relases and Analysis
About CEMP
Company Profile
Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, skin and skin structure infections and to target the growing problem of antimicrobial resistance. Cempra Holdings, LLC is headquartered in Chapel Hill, North Carolina.
Company Info
CEMPRA INC
6320 QUADRANGLE DRIVE SUITE 360
CHAPEL HILL NC 27517
CEO: David S. Zaccardelli
Phone: 919-313-6601
CEMPRA INC / CEMP FAQ
What does CEMP do?
Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, skin and skin structure infections and to target the growing problem of antimicrobial resistance. Cempra Holdings, LLC is headquartered in Chapel Hill, North Carolina.
What is the current price of CEMP stock?
The current stock price of CEMP is 2.325 null. The price increased by 1.09% in the last trading session.
Does CEMPRA INC pay dividends?
CEMP does not pay a dividend.
What is the ChartMill technical and fundamental rating of CEMP stock?
CEMP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Which stock exchange lists CEMP stock?
CEMP stock is listed on the Nasdaq exchange.
Can you provide the market cap for CEMPRA INC?
CEMPRA INC (CEMP) has a market capitalization of 122.09M null. This makes CEMP a Micro Cap stock.
CEMP Technical Analysis
CEMP Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CEMP. The financial health of CEMP is average, but there are quite some concerns on its profitability.
CEMP Financial Highlights
Over the last trailing twelve months CEMP reported a non-GAAP Earnings per Share(EPS) of -1.47. The EPS increased by 33.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -499.88% | ||
| ROA | -42.78% | ||
| ROE | -53.6% | ||
| Debt/Equity | 0.03 |